MGH McLean Adult Psychiatry Residency Program

Fonda with McLean President and Psychiatrist in Chief Scott Rauch, MD (left), and director David O. Russell (right).

McLean Hospital recently hosted a gala event to honor actress, author and mental health advocate Jane Fonda for her exceptional efforts to educate the public about mental health issues.

Director David O. Russell, who was honored by the hospital last year, actress Catherine Keener and actress/comedian Maya Rudolph, were among the 500 guests to show support for Fonda as she was presented with the coveted McLean Award –the hospital’s highest honor--at the InterContinental Hotel in Boston on Friday, June 20.

“I am grateful for the compassion that McLean brings to its work,” said Fonda, who eloquently and openly spoke about her mother’s suicide when Jane was just 12 years old and about her own struggle with an eating disorder.

In fitting Hollywood fashion, the evening concluded with a surprise ending when McLean President and Psychiatrist in Chief Scott L. Rauch and Board Chairman David S. Barlow presented Fonda with a portrait created by world-renowned Brazilian neo-pop artist Romero Britto.

June of every year is a significant time for PGY4 residents, and not just because it brings warmer weather. June is the time when PGY4 residents give their Senior Talk, a brief presentation what each resident has learned during their residency before the start their post residency careers. The subject of each talk varies, from an exploration of how shame affects both the patient and the psychiatrist to how creating a genetically modified mouse can help further our understanding of eating disorders. For a complete list of the speakers and their topics, please refer to the bottom of the article.

Additionally, each June the MGH/McLean recognizes some of our residents for their outstanding work in the clinic as well as in the lab. Please see below for the full list of award recipients.

• Hackett Award – Jennifer Gatchel, MD, PhD
• Joyce and Richard Tedlow Award – Rachel Ross, MD, PhD
• Paul Howard Award – Stephanie Cincotta, MD
• Ed Messner Award – Heather Vestal, MD, MHS
• Anne Alonso Award – Kathryn Tompkins, MD
• Mel Kayce Award – Christina Brezing, MD
• Laughlin Award – Alex Keuroghlian, MD, MSc
• Outstanding Contribution to Neuroscience Award – Evan Macosko, MD, PhD

Joan Camprodon, MD, MPH, PhD (Class of 2012), demonstrates the use of TMS on Amanda Arulpragasam, MGH Research Assistant

For patients suffering from depression, the Massachusetts General Hospital Department of Psychiatry now offers another treatment option – a new clinic based in Charlestown that uses transcranial magnetic stimulation (TMS). The clinic is part of a broader effort that includes a research enterprise program, both led by Joan Camprodon, MD, MPH, PhD, (Class of 2012) director of the Laboratory for Neuropsychiatry and Neuromodulation at Mass General. Dr. Camprodon’s team aims to understand how the brain’s structure and function affect disease and how interventions such as TMS can change the mechanisms that contribute to disease.

During a TMS procedure, focused magnetic impulses are directed to the brain. The electrical currents produced stimulate nerve cells involved in mood regulation that may be underactive in diseases such as depression. By restoring the equilibrium, TMS helps reset this imbalance of chemicals. from a diseased brain to a healthy one.